2019 annual financial data
Seres Therapeutics 2019 Financial results
Direct answer
Revenue was 34.51M USD.
Operating income was -71.88M USD and net income was -70.28M USD.
Operating cash flow was -76.52M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34.51M USD
- Operating income
- -71.88M USD
- Net income
- -70.28M USD
- Operating cash flow
- -76.52M USD
Explore related company data
View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Seres Therapeutics financial years